Compared with standard antihypertensive therapy, intensive antihypertensive therapy may significantly benefit women with T2D whose hypertension is diagnosed earlier in life.
Studies suggest that lower stroke risk associated with newer antidiabetic therapies is not due to the drugs' tighter glycemic control. So, what is the mechanism?
Subpopulations at heightened risk for ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) due to air pollution.
Although low-dose aspirin to reduce the risk for first-time heart attacks and strokes was the standard of care for 30 years, the risk-benefit calculation has changed.